Open-wound complications - ranging from mild infections to amputations and organ failures- claim the lives of approximately 5 million people annually[5] . Surgical intervention remains the primary treatment for wound-caused severe bleeding, but access to healthcare is limited in many parts of the world, necessitating the development of alternative mobile solutions. This research projectaimed to address this issue by designing a bandage tailored for the treatment of severe bleeding and wound recovery. Utilizing phytohemagglutinin (PHA) protein and chitosan, the bandage exhibited exceptional wound healing rates as well as infections prevention in both the in vitro and in vivo trials, showcasing it as a promising solution for wound management and haemorrhage control in diverse healthcare settings.